Global Gabapentin Drug Market Insights, Forecast to 2025

Global Gabapentin Drug Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Gabapentin Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Gabapentin Drug Market Size Growth Rate by Product
1.4.2 Capsule
1.4.3 Tablet
1.4.4 Oral solution
1.5 Market by End User
1.5.1 Global Gabapentin Drug Market Size Growth Rate by End User
1.5.2 Postherpetic neuralgia in adults
1.5.3 Partial onset seizures
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gabapentin Drug Market Size
2.1.1 Global Gabapentin Drug Revenue 2014-2025
2.1.2 Global Gabapentin Drug Sales 2014-2025
2.2 Gabapentin Drug Growth Rate by Regions
2.2.1 Global Gabapentin Drug Sales by Regions
2.2.2 Global Gabapentin Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Gabapentin Drug Sales by Manufacturers
3.1.1 Gabapentin Drug Sales by Manufacturers
3.1.2 Gabapentin Drug Sales Market Share by Manufacturers
3.1.3 Global Gabapentin Drug Market Concentration Ratio (CR5 and HHI)
3.2 Gabapentin Drug Revenue by Manufacturers
3.2.1 Gabapentin Drug Revenue by Manufacturers (2014-2019)
3.2.2 Gabapentin Drug Revenue Share by Manufacturers (2014-2019)
3.3 Gabapentin Drug Price by Manufacturers
3.4 Gabapentin Drug Manufacturing Base Distribution, Product Types
3.4.1 Gabapentin Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gabapentin Drug Product Type
3.4.3 Date of International Manufacturers Enter into Gabapentin Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Gabapentin Drug Sales by Product
4.2 Global Gabapentin Drug Revenue by Product
4.3 Gabapentin Drug Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Gabapentin Drug Breakdown Data by End User
6 North America
6.1 North America Gabapentin Drug by Countries
6.1.1 North America Gabapentin Drug Sales by Countries
6.1.2 North America Gabapentin Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Gabapentin Drug by Product
6.3 North America Gabapentin Drug by End User
7 Europe
7.1 Europe Gabapentin Drug by Countries
7.1.1 Europe Gabapentin Drug Sales by Countries
7.1.2 Europe Gabapentin Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gabapentin Drug by Product
7.3 Europe Gabapentin Drug by End User
8 Asia Pacific
8.1 Asia Pacific Gabapentin Drug by Countries
8.1.1 Asia Pacific Gabapentin Drug Sales by Countries
8.1.2 Asia Pacific Gabapentin Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Gabapentin Drug by Product
8.3 Asia Pacific Gabapentin Drug by End User
9 Central & South America
9.1 Central & South America Gabapentin Drug by Countries
9.1.1 Central & South America Gabapentin Drug Sales by Countries
9.1.2 Central & South America Gabapentin Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Gabapentin Drug by Product
9.3 Central & South America Gabapentin Drug by End User
10 Middle East and Africa
10.1 Middle East and Africa Gabapentin Drug by Countries
10.1.1 Middle East and Africa Gabapentin Drug Sales by Countries
10.1.2 Middle East and Africa Gabapentin Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Gabapentin Drug by Product
10.3 Middle East and Africa Gabapentin Drug by End User
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Gabapentin Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Gabapentin Drug Products Offered
11.1.5 Pfizer Recent Development
11.2 Depomed
11.2.1 Depomed Company Details
11.2.2 Company Business Overview
11.2.3 Depomed Gabapentin Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Depomed Gabapentin Drug Products Offered
11.2.5 Depomed Recent Development
11.3 Apotex
11.3.1 Apotex Company Details
11.3.2 Company Business Overview
11.3.3 Apotex Gabapentin Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Apotex Gabapentin Drug Products Offered
11.3.5 Apotex Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Company Business Overview
11.4.3 Teva Gabapentin Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Teva Gabapentin Drug Products Offered
11.4.5 Teva Recent Development
11.5 Acella Pharmaceuticals
11.5.1 Acella Pharmaceuticals Company Details
11.5.2 Company Business Overview
11.5.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Acella Pharmaceuticals Gabapentin Drug Products Offered
11.5.5 Acella Pharmaceuticals Recent Development
11.6 Taro
11.6.1 Taro Company Details
11.6.2 Company Business Overview
11.6.3 Taro Gabapentin Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Taro Gabapentin Drug Products Offered
11.6.5 Taro Recent Development
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Company Details
11.7.2 Company Business Overview
11.7.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Sun Pharmaceutical Gabapentin Drug Products Offered
11.7.5 Sun Pharmaceutical Recent Development
11.8 Glenmark
11.8.1 Glenmark Company Details
11.8.2 Company Business Overview
11.8.3 Glenmark Gabapentin Drug Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Glenmark Gabapentin Drug Products Offered
11.8.5 Glenmark Recent Development
11.9 Amneal Pharmaceuticals
11.9.1 Amneal Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Amneal Pharmaceuticals Gabapentin Drug Products Offered
11.9.5 Amneal Pharmaceuticals Recent Development
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Details
11.10.2 Company Business Overview
11.10.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Aurobindo Pharma Gabapentin Drug Products Offered
11.10.5 Aurobindo Pharma Recent Development
11.11 Zydus Pharmaceuticals
11.12 Hi-Tech Pharmaceuticals
11.13 Marksans Pharma
11.14 Mylan
11.15 InvaGen Pharmaceuticals
11.16 Alkem Laboratories
11.17 Tris Pharma
11.18 ACI HealthCare Limited
11.19 Jiangsu Hengrui Medicine
11.20 CSPC Ouyi Pharmaceutical
11.21 Sciegen Pharmaceuticals
11.22 Epic Pharma
11.23 Lupin Limited
12 Future Forecast
12.1 Gabapentin Drug Market Forecast by Regions
12.1.1 Global Gabapentin Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Gabapentin Drug Revenue Forecast by Regions 2019-2025
12.2 Gabapentin Drug Market Forecast by Product
12.2.1 Global Gabapentin Drug Sales Forecast by Product 2019-2025
12.2.2 Global Gabapentin Drug Revenue Forecast by Product 2019-2025
12.3 Gabapentin Drug Market Forecast by End User
12.4 North America Gabapentin Drug Forecast
12.5 Europe Gabapentin Drug Forecast
12.6 Asia Pacific Gabapentin Drug Forecast
12.7 Central & South America Gabapentin Drug Forecast
12.8 Middle East and Africa Gabapentin Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gabapentin Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Gabapentin Drug Product Picture
Table Gabapentin Drug Market Segments
Table Key Manufacturers Gabapentin Drug Covered
Table Global Gabapentin Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Gabapentin Drug Sales Market Share by Product 2014-2025
Figure Capsule Product Picture
Table Major Manufacturers of Capsule
Figure Tablet Product Picture
Table Major Manufacturers of Tablet
Figure Oral solution Product Picture
Table Major Manufacturers of Oral solution
Table Global Gabapentin Drug Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Postherpetic neuralgia in adults
Figure Partial onset seizures
Figure Others
Figure Gabapentin Drug Report Years Considered
Figure Global Gabapentin Drug Market Size 2014-2025 (Million US$)
Figure Global Gabapentin Drug Sales 2014-2025 (K Units)
Table Global Gabapentin Drug Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Gabapentin Drug Sales by Regions 2014-2019 (K Units)
Table Global Gabapentin Drug Sales Market Share by Regions 2014-2019
Figure Global Gabapentin Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Gabapentin Drug Sales Market Share by Regions
Table Global Gabapentin Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Gabapentin Drug Revenue Market Share by Regions 2014-2019
Figure Global Gabapentin Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Gabapentin Drug Revenue Market Share by Regions
Table Global Gabapentin Drug Sales by Manufacturers (2014-2019) (K Units)
Table Global Gabapentin Drug Sales Share by Manufacturers (2014-2019)
Figure Global Gabapentin Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Gabapentin Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Gabapentin Drug Revenue Share by Manufacturers (2014-2019)
Figure Gabapentin Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Gabapentin Drug Price (2014-2019) (USD/Unit)
Table Gabapentin Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Gabapentin Drug Product Type
Table Date of International Manufacturers Enter into Gabapentin Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Gabapentin Drug Sales by Product (2014-2019) (K Units)
Table Global Gabapentin Drug Sales Share by Product (2014-2019)
Figure Global Gabapentin Drug Sales Market Share by Product (2014-2019)
Figure Global Gabapentin Drug Sales Market Share by Product in 2018
Table Global Gabapentin Drug Revenue by Product (2014-2019) (Million US$)
Table Global Gabapentin Drug Revenue Share by Product (2014-2019)
Figure Global Gabapentin Drug Revenue Market Share by Product (2014-2019)
Figure Global Gabapentin Drug Revenue Market Share by Product in 2018
Table Gabapentin Drug Price by Product 2014-2019 (USD/Unit)
Table Global Gabapentin Drug Sales by End User (2014-2019) (K Units)
Table Global Gabapentin Drug Sales Share by End User (2014-2019)
Figure Global Sales Gabapentin Drug Market Share by End User (2014-2019)
Figure Global Sales Gabapentin Drug Market Share by End User in 2018
Figure North America Gabapentin Drug Sales Growth Rate 2014-2019 (K Units)
Figure North America Gabapentin Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Gabapentin Drug Sales by Countries (2014-2019) (K Units)
Table North America Gabapentin Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Gabapentin Drug Sales Market Share by Countries
Table North America Gabapentin Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Gabapentin Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Gabapentin Drug Revenue Market Share by Countries
Figure United States Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure United States Gabapentin Drug Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Canada Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Gabapentin Drug Sales by Product (2014-2019) (K Units)
Table North America Gabapentin Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Gabapentin Drug Market Share by Product
Table North America Gabapentin Drug Sales by End User (2014-2019) (K Units)
Table North America Gabapentin Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Gabapentin Drug Market Share by End User
Figure Europe Gabapentin Drug Sales Growth Rate 2014-2019 (K Units)
Figure Europe Gabapentin Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Gabapentin Drug Sales by Countries (2014-2019) (K Units)
Table Europe Gabapentin Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Gabapentin Drug Sales Market Share by Countries
Table Europe Gabapentin Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Gabapentin Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Gabapentin Drug Revenue Market Share by Countries
Figure Germany Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Germany Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure France Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure UK Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Italy Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Russia Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Gabapentin Drug Sales by Product (2014-2019) (K Units)
Table Europe Gabapentin Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Gabapentin Drug Market Share by Product
Table Europe Gabapentin Drug Sales by End User (2014-2019) (K Units)
Table Europe Gabapentin Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Gabapentin Drug Market Share by End User
Figure Asia Pacific Gabapentin Drug Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Gabapentin Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Gabapentin Drug Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Gabapentin Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Gabapentin Drug Sales Market Share by Countries
Table Asia Pacific Gabapentin Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Gabapentin Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Gabapentin Drug Revenue Market Share by Countries
Figure China Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure China Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Japan Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Korea Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure India Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Australia Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Gabapentin Drug Sales by Product (2014-2019) (K Units)
Table Asia Pacific Gabapentin Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Gabapentin Drug Market Share by Product
Table Asia Pacific Gabapentin Drug Sales by End User (2014-2019) (K Units)
Table Asia Pacific Gabapentin Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Gabapentin Drug Market Share by End User
Figure Central & South America Gabapentin Drug Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Gabapentin Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Gabapentin Drug Sales by Countries (2014-2019) (K Units)
Table Central & South America Gabapentin Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Gabapentin Drug Sales Market Share by Countries
Table Central & South America Gabapentin Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Gabapentin Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Gabapentin Drug Revenue Market Share by Countries
Figure Brazil Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Gabapentin Drug Sales by Product (2014-2019) (K Units)
Table Central & South America Gabapentin Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Gabapentin Drug Market Share by Product
Table Central & South America Gabapentin Drug Sales by End User (2014-2019) (K Units)
Table Central & South America Gabapentin Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Gabapentin Drug Market Share by End User
Figure Middle East and Africa Gabapentin Drug Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Gabapentin Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Gabapentin Drug Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Gabapentin Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Gabapentin Drug Sales Market Share by Countries
Table Middle East and Africa Gabapentin Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Gabapentin Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Gabapentin Drug Revenue Market Share by Countries
Figure GCC Countries Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Gabapentin Drug Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Gabapentin Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Gabapentin Drug Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Gabapentin Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Gabapentin Drug Market Share by Product
Table Middle East and Africa Gabapentin Drug Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Gabapentin Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Gabapentin Drug Market Share by End User
Table Pfizer Company Details
Table Pfizer Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Depomed Company Details
Table Depomed Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Depomed Recent Development
Table Apotex Company Details
Table Apotex Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Apotex Recent Development
Table Teva Company Details
Table Teva Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Recent Development
Table Acella Pharmaceuticals Company Details
Table Acella Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Acella Pharmaceuticals Recent Development
Table Taro Company Details
Table Taro Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Taro Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharmaceutical Recent Development
Table Glenmark Company Details
Table Glenmark Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Glenmark Recent Development
Table Amneal Pharmaceuticals Company Details
Table Amneal Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amneal Pharmaceuticals Recent Development
Table Aurobindo Pharma Company Details
Table Aurobindo Pharma Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Aurobindo Pharma Recent Development
Table Zydus Pharmaceuticals Company Details
Table Hi-Tech Pharmaceuticals Company Details
Table Marksans Pharma Company Details
Table Mylan Company Details
Table InvaGen Pharmaceuticals Company Details
Table Alkem Laboratories Company Details
Table Tris Pharma Company Details
Table ACI HealthCare Limited Company Details
Table Jiangsu Hengrui Medicine Company Details
Table CSPC Ouyi Pharmaceutical Company Details
Table Sciegen Pharmaceuticals Company Details
Table Epic Pharma Company Details
Table Lupin Limited Company Details
Table Global Gabapentin Drug Sales Forecast by Regions 2019-2025 (K Units)
Table Global Gabapentin Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Gabapentin Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Gabapentin Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Gabapentin Drug Sales Forecast by Product 2019-2025 (K Units)
Table Global Gabapentin Drug Sales Market Share Forecast by Product 2019-2025
Table Global Gabapentin Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Gabapentin Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Gabapentin Drug Sales Forecast by End User 2019-2025 (K Units)
Table Global Gabapentin Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Gabapentin Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Gabapentin Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Gabapentin Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Gabapentin Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Gabapentin Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Gabapentin Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Gabapentin Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Gabapentin Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Gabapentin Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Gabapentin Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Gabapentin Drug Value Chain
Table Gabapentin Drug Customers List
Table Gabapentin Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs